Table 2.
Variables of patients in subgroups, follow-up 24 months.
| Variables | HR-/HER2- N=20 (%) | HR+/HER2+ N=20 (%) | HR+/HER+ N=20 (%) | P-value* |
|---|---|---|---|---|
| Patients' age, years | ||||
| <35 | 1 (4.1) | 2 (12.9) | 1 (4.1) | 0.179 |
| 35–49 | 4 (20.4) | 7 (33.3) | 4 (20.4) | |
| 50–64 | 8 (42.1) | 7 (33.3) | 2 (12.9) | |
| ≥65 | 7 (33.3) | 4 (20.5) | 13 (62.1) | |
| Grade | ||||
| Well | 1 (4.1) | 0 (0) | 0 | 0.003 |
| Moderately | 7 (33.3) | 5 (25) | 2 (12.9) | |
| Poorly | 8 (41.2) | 13 (62.1) | 13 (62.1) | |
| Undifferentiated | 4 (20.4) | 2 (12.9) | 5 (25) | |
| Stage | ||||
| II | 5 (25) | 4 (20.4) | 4 (20.4) | 0.742 |
| III | 15 (75) | 16 (79.6) | 16 (79.6) | |
| Tumor size (millimeter) | ||||
| ≤10 | 1 (4.1) | 2 (12.9) | 4 (20.4) | 0.884 |
| 10–20 | 8 (42.2) | 1 (4.1) | 2 (12.9) | |
| 20–50 | 5 (25) | 4 (20.4) | 13 (62.1) | |
| >50 | 6 (28.7) | 13 (62.1) | 1 (4.1) | |
| Surgery | ||||
| Mastectomy | 7 (33.3) | 4 (20.4) | 5 (25) | 0.690 |
| BCS (breast-conserving surgery) | 13 (66.7) | 16 (79.6) | 15 (75) | |
| Result of the treatment | ||||
| Without recurrence | 16 (79.6) | 18 (95.9) | 17 (85.2) | <0.001 |
| With recurrence | 4 (20.4) | 1 (4.1) | 3 (14.8) | |
*
– p-values calculated by Pearson Chi squared testing; Bold if statistically significant, p<0.05; HR – hormone receptor.